Compare Stocks
Compare up to four stocks to (AXDX) by adding the symbol or company name.
AXDX
Compare up to three stocks to AXDX by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value 19.71M | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV 45.30M | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings 0.22 | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM -4.94 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
Industry | Industry Medical Devices | Industry -- | Industry -- | Industry -- |
CEO | CEO Mr. Jack Phillips | CEO -- | CEO -- | CEO -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week -1.09% | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months -24.17% | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD -76.79% | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year -87.87% | 1 Year -- | 1 Year -- | 1 Year -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue 12.06M | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses 56.58M | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income -54.03M | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y 1.85% | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit 2.55M | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory 3.31M | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover 4.79 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops -40.20M | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx -1.03M | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI 8.66M | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow -41.23M | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E 0.22 | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF -- | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV -- | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S 0.92 | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA -0.92 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin -448.03% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin 21.15% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin -510.97% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS -4.94 | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth 0.00% | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets -127.86% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital -51.28% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of May 15, 2024 | AXDX Accelerate Diagnostics, Inc. | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % 12.94% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |